CLINICAL DATA REVIEW
Detect safety signals faster and reduce time to submission with innovative workflows and advanced analytics.Learn More
Timely information and actionable insights that enable optimal study start-up, budget, and milestone tracking.Learn More
Data-driven insights to optimize site performance while improving patient safety.Learn More
Visual analytics to accelerate the response to safety issues while facilitating regulatory compliance.Learn More
CLINICAL DATA REVIEW
Innovative Workflows and Advanced Analytics Enabling Patient Safety
Revvity’s Clinical Data Review solutions are designed to address the multifarious challenges of analyzing clinical trial data and put in place robust strategies to overcome these hurdles. They provide users with speed, agility, and tailored analytics to identify risks early, accelerating the time to bring important therapies to market safely.
Powered by TIBCO® Spotfire®, these solutions can be integrated within an existing ecosystem or used as stand-alone platforms to support a specific clinical need, providing unrivaled flexibility to support all your clinical data review needs.
Watch a quick demo to see how easy it is to drill across study level patient populations, down to the individual patient profile level.
Watch a quick demo of how to use Hy’s Law to spot DILI with our Clinical Data Review solution.
The Most Effective Way to Leverage Data-Driven Insights
Revvity’s solution for Risk-Based Monitoring enables organizations with TIBCO® Spotfire® visual analytics to quickly identify and track actions for high- risk sites. Using Translcerate’s best practices, our solution employs 20 key risk indicators configurable for each study or therapy. From study start-up to database lock, your organization can adjust the weighting of each key risk indicator to reflect the status of your trial and your priorities.
Optimize Site Performance While Improving Patient Safety
Our Risk-Based Monitoring solution empower users with visual analytics to proactively monitor clinical trial data from various source systems, contributing to more efficient trial execution and rapid identification of patient safety and data quality issues.
Quickly identify and track actions for high-risk sites
Reduce complexity by supporting multiple trial designs and data sources
Optimize monitoring using adaptive risk models applied to historical study data
Better Insights Lead to Better Patient Protection
Revvity’s Pharmacovigilance solution enables organizations with TIBCO® Spotfire® visual analytics to accelerate the response to safety issues while facilitating regulatory compliance. Our solutions focus on safety case analysis and medical safety review and are extendable to drive signal detection and data reconciliation. By deploying these analytics across your entire portfolio, study teams are enabled to take a more strategic approach to their medical and safety review.
• Accelerate Response to Safety Issues
• Enhance Protection of Patients
• Maintain Good Standing with Regulators
Watch our on-demand webinar to learn how extending analytics beyond CDR to pharmacovigilance can lead to better managed studies.
Enhancing Your Clinical Data Review Process
Signals Line Listing Review leverages TIBCO® Spotfire’s® interactive capabilities to enable clinical study teams to review, query, and track the status of their line listings in a collaborative, centralized, and scalable environment.
Watch our video to learn how Signals Line Listing Review can help your team ensure patient safety, monitor study progress and quickly identify trends.
The Revvity Signals Clinical analytics platform, powered by global analytics leader TIBCO® Spotfire®, provides a portfolio of purpose-built solutions that help improve efficiency across functional teams within Clinical Development. Our solutions support every use case, are fully customizable, and can harmonize real-time access to data from multiple sources throughout all phases of clinical development. Accessing the right data at the right time helps accelerate decisions and drive innovation from concept through trial completion and regulatory approvals, becoming an essential part of the pharmaceutical Research & Development workflow.